TECHNOLOGY
APPLICATION
TECHNOLOGY EVOLVED
A Platform, Not a Product
HypoSpray® is a proprietary co-processed excipient delivery system engineered to support dermal availability of active ingredients without the use of patches, devices, or energy-assisted modalities.
The platform is designed to integrate seamlessly into provider-managed care models where repeatable administration, patient acceptance, and operational simplicity matter.
What HypoSpray Is
-
A co-processed excipient delivery platform
-
Molecule-agnostic by design
-
Supplied to licensed pharmacy and clinical partners
-
Designed for repeatable, needle-free administration
What HypoSpray Is Not
-
Not a finished drug product
-
Not a patch or wearable device
-
Not iontophoresis or phonophoresis
-
Not marketed directly to consumers
How the Platform Works (Conceptual)
The HypoSpray platform leverages co-processed excipients to create a delivery environment that supports:
-
Solubilization of active ingredients
-
Stability within defined formulation parameters
-
Consistent application characteristics suitable for provider-directed use
The technology is designed to function as a delivery layer, adaptable across multiple APIs, rather than a single-indication solution.
No claims are made regarding clinical outcomes, bioavailability equivalence, or therapeutic efficacy. All medical decisions remain with licensed healthcare providers.
Platform Scope
The HypoSpray delivery architecture is intended to be adaptable across a range of active ingredient categories, subject to partner formulation, regulatory review, and provider oversight.
​
The platform’s value lies in delivery optionality, not molecule dependency.
​
Guidance on fomrulation is available and the system has been available in a limited fashion for over a year in beta testing.
​
The solution seems to stabilize its payload in solution at room temperature.
​
Preparing a prescription or custom fill is a simple process of weighing out the correcct amount of compound to be delivered, measuring the appropriate amount of Coprocessed excipient solution and admixing, dispensed in a metered package.
Regulatory Posture
HYPOSPRAY Pharma:
-
Does not prescribe, diagnose, or treat patients
-
Does not market drugs to consumers
-
Supplies delivery technology to licensed partners
All medical decisions, prescribing, and patient management are conducted independently by licensed healthcare providers in accordance with applicable law.
PARTNER INQUIRIES
HypoSpray Pharma works with:
-
Telemedicine platforms
-
Integrated clinics & pharmacies
-
Strategic partners evaluating delivery infrastructure
If your organization is exploring transdermal delivery as part of a provider-managed care model, we invite you to initiate a discussion.